Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Pages 141-147 , June 2010

Controversies in bilirubin biochemistry and their clinical relevance

References 

  1. Jones RN. A yellow-stained human femur from Tell esh-Shuqafiya, Egypt – evidence of ancient trauma. Am J Phys Anthropol. 1988;77:77–83
  2. Thénard LJ. Traité de chimie élémentaire, théorique et pratique. 6th ed.. Paris: Crochard & Cie; 1836;p. 148
  3. Orth J. Ueber das Vorkommen von Bilirubinkrystallen bei neugeborenen Kindern. Virchows Arch Pathol Anat. 1875;63:447–462
  4. Pirone C, Quirke JM, Priestap HA, Lee DW. Animal pigment bilirubin discovered in plants. J Am Chem Soc. 2009;131:2830
  5. Wang J, Ortiz de Montellano PR. The binding sites on human heme oxygenase-1 for cytochrome P450 reductase and biliverdin reductase. J Biol Chem. 2003;278:20069–20076
  6. Blake MJ, Castro L, Leeder JS, Kearns GL. Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med. 2005;10:123–138
  7. Nies A, Keppler D. The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch. 2007;453:643–659
  8. Gåfvels M, Holmström P, Somell A, et al. A novel mutation in the biliverdin reductase-A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice). Liver Int. 2009;29:1116–1124
  9. Kappas A. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics. 2004;113:119–123
  10. Vreman HJ, Wong RJ, Stevenson D. Alternative metalloporphyrins for the treatment of neonatal jaundice. J Perinatol. 2001;21(Suppl. 1):S108–S113
  11. Bonnett R, Davies JE, Hursthouse MB, Sheldrick GM. Structure of bilirubin. Proc R Soc Lond B Biol Sci. 1978;202:249–268
  12. Nogales D, Lightner DA. On the structure of bilirubin in solution. 13C{1H} heteronuclear Overhauser effect NMR analyses in aqueous buffer and organic solvents. J Biol Chem. 1995;270:73–77
  13. McDonagh A, Lightner D. Influence of conformation and intramolecular hydrogen bonding on the acyl glucuronidation and biliary excretion of acetylenic bis-dipyrrinones related to bilirubin. J Med Chem. 2007;50:480–488
  14. McDonagh AF, Lightner DA. ‘Like a shrivelled blood orange’ – bilirubin, jaundice, and phototherapy. Pediatrics. 1985;75:443–455
  15. McDonagh A. Lyophilic properties of protoporphyrin and bilirubin. Hepatology. 2002;36:1028–1029
  16. Zunszain PA, Ghuman J, McDonagh A, Curry S. Crystallographic analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXα. J Mol Biol. 2008;381:394–406
  17. Vitek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des. 2009;15:2869–2883
  18. Manitto P, Monti D. Photoaddition of sulphydryl groups to bilirubin in vitro. Experientia. 1972;28:379–380
  19. Lightner D, An J, Pu Y. Circular-dichroism of bilirubin-amine association complexes: insights into bilirubin-albumin binding. Arch Biochem Biophys. 1988;262:543–559
  20. Lightner DA. Structure, photochemistry, and organic chemistry of bilirubin. In:  Heirwegh KPM,  Brown SB editor. Bilirubin. Boca Raton: CRC Press; 1982;p. 1–58
  21. Agati G, McDonagh A. Chiroptical switch based on photoisomerization of bilirubin-IIIα bound to human serum albumin. J Am Chem Soc. 1995;117:4425–4426
  22. McDonagh AF, Palma LA, Lauff JJ, Wu TW. Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. J Clin Invest. 1984;74:763–770
  23. Myara A, Sender A, Valette V, et al. Early changes in cutaneous bilirubin and serum bilirubin isomers during intensive phototherapy of jaundiced neonates with blue and green light. Biol Neonate. 1997;71:75–82
  24. Cui Y, König J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001;276:9626–9630
  25. Wang P, Kim RB, Chowdhury JR, Wolkoff AW. The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport. J Biol Chem. 2003;278:20695–20699
  26. Zucker SD, Goessling W, Hoppin AG. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem. 1999;274:10852–10862
  27. Watchko J, Daood M, Hansen TW. Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice. Pediatr Res. 1998;44:763–766
  28. Watchko J, Daood M, Mahmood B, et al. P-glycoprotein and bilirubin disposition. J Perinatol. 2001;21(Suppl. 1):S43–S47
  29. Serrano MA, Bayón JE, Pascolo L, et al. Evidence for carrier-mediated transport of unconjugated bilirubin across plasma membrane vesicles from human placental trophoblast. Placenta. 2002;23:527–535
  30. McDonagh A. Movement of bilirubin and bilirubin conjugates across the placenta. Pediatrics. 2007;119:1032–1033
  31. Gajdos V, Petit F, Trioche P, et al. Successful pregnancy in a Crigler–Najjar type I patient treated by phototherapy and semimonthly albumin infusions. Gastroenterology. 2006;131:921–924
  32. Lipsitz PJ, Flaxman LM, Tartow LR, Malek BK. Maternal hyperbilirubinemia and the newborn. Am J Dis Child. 1973;126:525–527
  33. Smitherman H, Stark A, Bhutani V. Early recognition of neonatal hyperbilirubinemia and its emergent management. Semin Fetal Neonatal Med. 2006;11:214–224
  34. Ostrow JD, Pascolo L, Brites D, Tiribelli C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med. 2004;10:65–70
  35. Tiribelli C, Ostrow JD. The molecular basis of bilirubin encephalopathy and toxicity: report of an EASL Single Topic Conference, Trieste, Italy, 1–2 October, 2004. J Hepatol. 2005;43:156–166
  36. Watchko JF. Kernicterus and the molecular mechanisms of bilirubin-induced CNS injury in newborns. Neuromolecular Med. 2006;8:513–529
  37. Feng BY, Toyama BH, Wille H, et al. Small-molecule aggregates inhibit amyloid polymerization. Nat Chem Biol. 2008;4:197–199
  38. McDonagh AF. Bile pigments. Biladienes and 5,15-bilatrienes. In:  Dolphin D editors. The porphyrins. New York: Academic Press; 1979;p. 293–491
  39. Geiger A, Rice AC, Shapiro SM. Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats. Neonatology. 2007;92:219–226
  40. Lin S, Wei X, Bales K, et al. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat. Eur J Neurosci. 2005;22:21–27
  41. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal. 2004;6:841–849
  42. Soares M, Bach F. Heme oxygenase-1: from biology to therapeutic potential. Trends Mol Med. 2009;15:50–58
  43. Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA. 2002;99:16093–16098
  44. Sedlak TW, Saleh M, Higginson DS, et al. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci USA. 2009;106:5171–5176
  45. Sedlak TW, Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics. 2004;113:1776–1782
  46. Maghzal GJ, Leck MC, Collinson E, Li C, Stocker R. Limited role for the bilirubin–biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase. J Biol Chem. 2009;284:2951–2959
  47. De Matteis F, Lord G. Desferrioxamine dehydrogenates bilirubin in two stages, leading to a 1:1 red-coloured adduct. Characterization of the products by high-performance liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom. 2008;22:4055–4065
  48. Hatfield GL, Barclay LRC. Bilirubin as an antioxidant: kinetic studies of the reaction of bilirubin with peroxyl radicals in solution, micelles, and lipid bilayers. Org Lett. 2004;6:1539–1542
  49. Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics. 2006;118:276–279
  50. McDonagh AF. The role of singlet oxygen in bilirubin photo-oxidation. Biochem Biophys Res Commun. 1971;44:1306
  51. Maisels MJ, Kring EA. Does intensive phototherapy produce hemolysis in newborns of 35 or more weeks gestation?. J Perinatol. 2006;26:498–500
  52. Cheung WH, Sawitsky A, Isenberg HD. Effect of bilirubin on mammalian erythrocyte. Transfusion. 1966;6:475–486
  53. Brito MA, Rosa AI, Falcão AS, et al. Unconjugated bilirubin differentially affects the redox status of neuronal and astroglial cells. Neurobiol Dis. 2008;29:30–40
  54. McDonagh A. Bilirubin toxicity to human erythrocytes: a more sanguine view. Pediatrics. 2007;120:175–178
  55. Mireles LC, Lum MA, Dennery PA. Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr Res. 1999;45:355–362
  56. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358:920–928
  57. Ahlfors CE, Wennberg RP, Ostrow JD, Tiribelli C. Unbound (free) bilirubin: improving the paradigm for evaluating neonatal jaundice. Clin Chem. 2009;55:1288–1299
  58. Daood MJ, McDonagh AF, Watchko JF. Calculated free bilirubin levels and neurotoxicity. J Perinatol. 2009;29(Suppl. 1):S14–S19
  59. McDonagh A, Vreman HJ, Wong RJ, Stevenson DK. Photoisomers: obfuscating factors in clinical peroxidase measurements of unbound bilirubin?. Pediatrics. 2009;123:67–76
  60. Ahlfors CE, Marshall GD, Wolcott DK, Olson DC, Van Overmeire B. Measurement of unbound bilirubin by the peroxidase test using zone fluidics. Clin Chim Acta. 2006;365:78–85
  61. Wells R, Hammond K, Lamola AA, Blumberg WE. Relationships of bilirubin binding parameters. Clin Chem. 1982;28:432–439

PII: S1744-165X(09)00105-X

doi: 10.1016/j.siny.2009.10.005

Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 3 , Pages 141-147 , June 2010

Article Tools

* Image Usage & Resolution